| 2025年中报 | 2024年年报 | 2024年一季报 | 2023年年报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 原料药及中间体(元) | 282,370,423.88 | 591,495,054.45 | 161,652,191.95 | 646,576,024.00 |
| 制剂(元) | 85,197,092.62 | 172,011,032.34 | 42,369,016.16 | 98,567,735.16 |
| 其他类型(元) | 1,568,743.37 | 11,589,059.77 | 2,420,919.48 | 20,760,142.96 |
| 营业成本(元) | ||||
| 原料药及中间体(元) | 199,491,670.27 | 402,149,486.64 | 110,432,080.97 | 463,462,970.23 |
| 制剂(元) | 30,666,003.62 | 83,698,446.42 | 16,199,697.12 | 55,128,196.04 |
| 其他类型(元) | 920,978.11 | 2,690,664.05 | 230,824.51 | 4,691,105.88 |
| 毛利(元) | ||||
| 原料药及中间体(元) | 82,878,753.61 | 189,345,567.81 | 51,220,110.98 | 183,113,053.77 |
| 制剂(元) | 54,531,089.00 | 88,312,585.92 | 26,169,319.04 | 43,439,539.12 |
| 其他类型(元) | 647,765.26 | 8,898,395.72 | 2,190,094.97 | 16,069,037.08 |
| 毛利率(%) | ||||
| 原料药及中间体(%) | 29.35 | 32.01 | 31.69 | 28.32 |
| 制剂(%) | 64.01 | 51.34 | 61.77 | 44.07 |
| 其他类型(%) | 41.29 | 76.78 | 90.47 | 77.40 |
| 收入构成(%) | ||||
| 原料药及中间体(%) | 76.49 | 76.31 | 78.30 | 84.42 |
| 制剂(%) | 23.08 | 22.19 | 20.52 | 12.87 |
| 其他类型(%) | 0.42 | 1.50 | 1.17 | 2.71 |
| 毛利构成(%) | ||||
| 原料药及中间体(%) | 60.03 | 66.08 | 64.36 | 75.47 |
| 制剂(%) | 39.50 | 30.82 | 32.88 | 17.90 |
| 其他类型(%) | 0.47 | 3.11 | 2.75 | 6.62 |